Invent Medic appoints Honeybadger as the company’s IR communication partner
Invent Medic announces that the company will increase and strengthen its market communication together with the IR communication agency Honeybadger. The collaboration includes a strategic communication plan as well as ongoing and periodic communication.
As a part of this venture, Honeybadger is appointed as Invent Medic’s IR communication partner in accordance with an ongoing contract. Honeybadger undertakes to assist Invent Medic with strategic advice as well as in the production of regulatory and non-regulatory market communication in Swedish and English. The contract also includes updating existing web solutions and the possibility to conduct PR campaigns targeted at Swedish industry and business media.
"Invent Medic has shown great progress in 2018, with the launch of our first product Efemia bladder support in October as the most important event. This is expected to increase our market communication going forward. We have therefore decided to upgrade our capabilities in this area together with Honeybadger, based on their ability to combine a strategic and creative mindset with efficient execution. So far, we have used their services with great results since the production of our latest interim report,” says Invent Medic’s CEO Karin Bryder.
"Invent Medic’s first product shows the strength in the company’s ability to improve women’s health and quality of life with innovative solutions. This vision is completely in line with our core values, and we look forward to developing their communication with important target groups such as shareholders, investors and the media,” says Honeybadger’s CEO Johan Waldhe.
For more information, please contact
Karin Bryder, CEO
Telephone: +46 (0) 723 811 710
Email: info@inventmedic.com
About Invent Medic
Invent Medic Sweden AB (Invent Medic) is a Swedish company developing innovative products with the aim to improve women’s health and quality of life. The company’s products are to be safe, effective and easy to use. The finished women’s health products are sold through the company’s Arcamea brand. Invent Medic’s first product, Efemia, is a CE-certified and patented medical technology product used to reduce stress urinary incontinence (SUI) that was shown to reduce urine leakage with 77 percent during usage in a clinical study. The product is based on the same scientific principle as the TVT method, the premier surgical treatment for SUI. Invent Medic’s share is listed on the Spotlight Stock Market with the ticker symbol IMS, and the share’s ISIN code is SE0007603402. More information can be found at www.inventmedic.com and www.spotlightstockmarket.com.
About Honeybadger
Honeybadger AB is an IR communications agency based in Gothenburg, Sweden with a high-quality mindset used to create effective and transparent communication together with listed companies. We focus on clients with the potential to improve the living conditions for humans, animals and nature through scientific and technological advancements. Honeybadger is based on over 15 years of experience in communication and marketing for listed companies and corporations in the financial sector.